Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 3.38% is 1837% above its 3-year average of 0.17%, near the high end of its 3-year range (-2.78%–3.45%).
As of the fiscal period ended Tuesday, June 30, 2026. 8.15% above its 12-month average of 3.13%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 3.38%.
RETURN ON EQUITY (ROE)
3.38%
RETURN ON EQUITY (ROE) AVG TTM
3.13%
RETURN ON EQUITY (ROE) AVG 3Y
0.17%
RETURN ON EQUITY (ROE) AVG 5Y
N/A
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+8.15%
CURRENT VS 3Y AVG
+1837.41%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 753 covered companies
CURRENT VS SECTOR MEDIAN
+108.05%
vs the sector median at left
Waystar Holding Corp.
Market Cap
$5.06B
Return on Equity (ROE)
3.38%
TTM Avg
3.13%
3Y Avg
0.17%
5Y Avg
N/A
Market Cap
$5.07B
Return on Equity (ROE)
8.67%
TTM Avg
8.42%
3Y Avg
7.80%
5Y Avg
5.80%
Market Cap
$5.09B
Return on Equity (ROE)
-161.00%
TTM Avg
-110.38%
3Y Avg
-86.51%
5Y Avg
-75.97%
Market Cap
$4.96B
Return on Equity (ROE)
-79.37%
TTM Avg
-38.23%
3Y Avg
-43.73%
5Y Avg
-49.41%
Market Cap
$5.19B
Return on Equity (ROE)
-70.85%
TTM Avg
-75.76%
3Y Avg
-70.25%
5Y Avg
-57.77%
Market Cap
$5.20B
Return on Equity (ROE)
18.24%
TTM Avg
20.62%
3Y Avg
17.32%
5Y Avg
27.02%
Market Cap
$5.20B
Return on Equity (ROE)
24.56%
TTM Avg
11.91%
3Y Avg
-7.82%
5Y Avg
-3.31%
Market Cap
$5.21B
Return on Equity (ROE)
-177.24%
TTM Avg
-283.26%
3Y Avg
-317.97%
5Y Avg
-235.28%
Market Cap
$5.21B
Return on Equity (ROE)
-25.83%
TTM Avg
-24.61%
3Y Avg
-23.01%
5Y Avg
-16.21%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Waystar Holding Corp. (WAY) | $5.06B | 3.38% | 3.13% | 0.17% | N/A |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.07B | 8.67% | 8.42% | 7.80% | 5.80% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.09B | -161.00% | -110.38% | -86.51% | -75.97% |
| Erasca, Inc. (ERAS)vs › | $4.96B | -79.37% | -38.23% | -43.73% | -49.41% |
| Cogent Biosciences, Inc. (COGT)vs › | $5.19B | -70.85% | -75.76% | -70.25% | -57.77% |
| Doximity, Inc. (DOCS)vs › | $5.20B | 18.24% | 20.62% | 17.32% | 27.02% |
| Sotera Health Company (SHC)vs › | $5.20B | 24.56% | 11.91% | -7.82% | -3.31% |
| Travere Therapeutics, Inc. (TVTX)vs › | $5.21B | -177.24% | -283.26% | -317.97% | -235.28% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.21B | -25.83% | -24.61% | -23.01% | -16.21% |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.84B | -11.92% | -22.12% | -20.62% | -23.54% |
ROE
3.4%
ROA
2.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 3.38% |
| 2026-03-31 | 3.20% |
| 2025-12-31 | 2.89% |
| 2025-09-30 | 3.45% |
| 2025-06-30 | 2.71% |
| 2025-03-31 | 0.83% |
| 2024-12-31 | -0.62% |
| 2024-09-30 | -1.72% |
| 2024-06-30 | -2.50% |
| 2024-03-31 | -2.78% |
| 2023-12-31 | -2.50% |
| 2023-09-30 | -2.16% |
| 2023-06-30 | -1.91% |
